These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1268 related articles for article (PubMed ID: 23334791)

  • 21. NK cells and type 1 innate lymphoid cells: partners in host defense.
    Spits H; Bernink JH; Lanier L
    Nat Immunol; 2016 Jun; 17(7):758-64. PubMed ID: 27328005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
    Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
    J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
    Qiu J; Zhou L
    Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
    Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
    Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lineage relationship analysis of RORgammat+ innate lymphoid cells.
    Sawa S; Cherrier M; Lochner M; Satoh-Takayama N; Fehling HJ; Langa F; Di Santo JP; Eberl G
    Science; 2010 Oct; 330(6004):665-9. PubMed ID: 20929731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting human ILC heterogeneity: more than just three subsets.
    Simoni Y; Newell EW
    Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
    Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
    Front Immunol; 2019; 10():217. PubMed ID: 30828332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
    Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
    Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Runx3 specifies lineage commitment of innate lymphoid cells.
    Ebihara T; Song C; Ryu SH; Plougastel-Douglas B; Yang L; Levanon D; Groner Y; Bern MD; Stappenbeck TS; Colonna M; Egawa T; Yokoyama WM
    Nat Immunol; 2015 Nov; 16(11):1124-33. PubMed ID: 26414766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enrichment of IL-17A
    Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
    Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells.
    Melo-Gonzalez F; Hepworth MR
    Immunology; 2017 Mar; 150(3):265-275. PubMed ID: 27935637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversity and function of group 1 innate lymphoid cells.
    Cortez VS; Colonna M
    Immunol Lett; 2016 Nov; 179():19-24. PubMed ID: 27394699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.
    Silver JS; Kearley J; Copenhaver AM; Sanden C; Mori M; Yu L; Pritchard GH; Berlin AA; Hunter CA; Bowler R; Erjefalt JS; Kolbeck R; Humbles AA
    Nat Immunol; 2016 Jun; 17(6):626-35. PubMed ID: 27111143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NCR
    Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
    Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
    Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
    Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.